Spring Bank

Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH), a micro-cap, clinical-stage biopharmaceutical company that develops novel therapeutics for the treatment of viral infections, opened at $11.28 on Friday, 6 percent below the IPO price, which was set at $12.00 per share. Trading is scheduled to...